MedTrace Logo

Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia

NCT02099552 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2017-09-05

No results posted yet for this study

Summary

The proposed natural history study will enroll male and female patients, ages 36 months and younger, who have a diagnosis of XLHED based on genetic testing and who have not received an investigational study drug. The study protocol will include collection of all relevant medical history and documentation of clinical outcomes using age-appropriate, minimally invasive technologies. Data will be collected both retrospectively, back to pregnancy assessments that may be available, and prospectively through age 5 yrs.

Conditions

  • X-Linked Hypohidrotic Ectodermal Dysplasia

Sponsors & Collaborators

  • Edimer Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Ramsey Johnson, MSM · Edimer Pharmaceuticals

Eligibility

Max Age
36 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States
  • France
  • Germany
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02099552 on ClinicalTrials.gov